Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 5Recruiting 5Not yet recruiting 3Completed 2Active not recruiting 2Terminated 1

Sponsor Class

INDUSTRY 137OTHER 128NIH 17OTHER_GOV 2NETWORK 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 107Neoplasms 80Colorectal Neoplasms 54Uterine Cervical Neoplasms 29Stomach Neoplasms 29Lung Neoplasms 27Rectal Neoplasms 25Prostatic Neoplasms 25Colonic Neoplasms 24Polycystic Ovary Syndrome 22Pancreatic Neoplasms 22Head and Neck Neoplasms 17Endometrial Neoplasms 17Carcinoma, Non-Small-Cell Lung 16Carcinoma, Hepatocellular 16Pain 15Neoplasm Metastasis 15Motor Activity 15Esophageal Neoplasms 15Ovarian Neoplasms 13Urinary Bladder Neoplasms 11Lymphoma 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Pain, Postoperative 10Melanoma 10Thyroid Neoplasms 9Pilonidal Sinus 9Multiple Myeloma 9Gastrointestinal Neoplasms 9Sarcopenia 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × OTHER_GOV × Triple Negative Breast Neoplasms × Clear all
NCT04664972 2024-09-20

Comparison of TP and TAC Regimens in Neoadjuvant Treatment of TNBC

Henan Cancer Hospital

Phase 2 Completed
212 enrolled
Breast

Triple Negative Breast Neoplasms

NCT03539965 2018-05-31

TNBCbrazil

Instituto Nacional de Cancer, Brazil

Completed
239 enrolled
Breast

Pathologic Complete Response, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡